Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study.
Alayed Y, Loblaw A, Chu W, Al-Hanaqta M, Chiang A, Jain S, Chung H, Vesprini D, Morton G, Ravi A, Davidson M, Deabreu A, Mamedov A, Zhang L, Erler D, Cheung P. Alayed Y, et al. Among authors: chung h. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1066-1073. doi: 10.1016/j.ijrobp.2019.04.006. Epub 2019 Apr 16. Int J Radiat Oncol Biol Phys. 2019. PMID: 31002941 Clinical Trial.
Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer.
Morton GC, Loblaw DA, Chung H, Tsang G, Sankreacha R, Deabreu A, Zhang L, Mamedov A, Cheung P, Batchelar D, Danjoux C, Szumacher E. Morton GC, et al. Among authors: chung h. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1299-305. doi: 10.1016/j.ijrobp.2010.04.046. Epub 2010 Aug 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 20708853 Clinical Trial.
A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost.
Helou J, Morton G, Zhang L, Deabreu A, D'Alimonte L, Elias E, Musunuru HB, Mamedov A, Ravi A, Chung H, Cheung P, Loblaw A. Helou J, et al. Among authors: chung h. Radiother Oncol. 2014 Dec;113(3):404-9. doi: 10.1016/j.radonc.2014.10.013. Epub 2014 Nov 14. Radiother Oncol. 2014. PMID: 25466371 Clinical Trial.
High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success.
Helou J, D'Alimonte L, Loblaw A, Chung H, Cheung P, Szumacher E, Danjoux C, Ravi A, Deabreu A, Zhang L, Morton G. Helou J, et al. Among authors: chung h. Radiother Oncol. 2015 Apr;115(1):84-9. doi: 10.1016/j.radonc.2015.02.023. Epub 2015 Mar 11. Radiother Oncol. 2015. PMID: 25770875
Computed Tomography Evaluation of Density Following Stereotactic Body Radiation Therapy of Nonspine Bone Metastases.
McDonald R, Probyn L, Poon I, Erler D, Brotherston D, Soliman H, Cheung P, Chung H, Chu W, Loblaw A, Thavarajah N, Lang C, Chin L, Chow E, Sahgal A. McDonald R, et al. Among authors: chung h. Technol Cancer Res Treat. 2016 Oct;15(5):683-8. doi: 10.1177/1533034615604068. Epub 2015 Sep 7. Technol Cancer Res Treat. 2016. PMID: 26351302 Free article.
9,575 results